For those of us who have been in the field for decades, this cycle of exhilaration or despair is common and manageable, but recent months have raised even further uncertainty about how progress in ...

The National Comprehensive Cancer Network hosted an Oncology Policy Summit in Washington, D.C., today, focused on improving ...

A team of researchers explain how navigation programs work, who benefits, and how to create a successful navigation program.

So, how can the hurdles to continued healthcare provider (HCP) and patient adoption be overcome in this saturated ... with their limited apps. Whilst standard PaaS (platform as a service ...

Leading cancer researchers from UC San Francisco presented talks about advances in targeted therapies, cancer genomics, using AI to personalize cancer treatment, improving diagnosis of hard-to-treat ...

The Gazette will host a series of free, virtual panel discussions this week aimed at exploring Iowa's cancer rates, the ...

Nanobiotix has presented complete outcomes from the dose escalation and dose expansion phases of the Phase I trial of ...

“With FDA approval due in 2019, it appears that Keytruda/Inlyta will and should become a new standard of care for the renal cancer patient population after posting this trial data.” The combo ...

Durvalumab plus full BCG significantly improved disease-free survival in high-risk early bladder cancer vs BCG alone in the ...

The use of RWD data in place of placebo groups is improving various elements across the clinical trial space.

On this World Ovarian Cancer Day learn about the latest advances in treatment and research From genetic testing to CAR T-cell ...

The success of AI in healthcare is influenced more by human factors and organizational readiness than by the technology ...